-
Mesothelioma Victims Return to Legal Action Against Johnson & Johnson’s
Following a bankruptcy judge’s ruling that lawsuits against Johnson & Johnson can move forward, almost two dozen individuals diagnosed with malignant mesothelioma have renewed their legal process. The claims had been put on hold as a result of the company’s previous bankruptcy proceeding.
-
Spurred by Concerns Over Mesothelioma, Congressional Leaders Reintroduce Bill to Ban Asbestos
Despite decades of research establishing a clear link between exposure to asbestos and malignant mesothelioma, the United States remains one of the few developed countries that has yet to ban the carcinogenic substance. Following recent reporting on unsafe conditions in American factories, members of Congress are renewing their efforts to pass the Alan Reinstein Ban
-
Mesothelioma Widow Files Suit to Counter Asbestos Company’s Bankruptcy Claim
Linda Cook’s husband Roland Cook died of malignant mesothelioma after having worked with asbestos gaskets manufactured by a predecessor to Reinz Wisconsin Gasket, LLC (RWG). Shortly after the couple had filed a personal injury lawsuit and Mr. Cook died, Mrs. Cook was notified that the company had filed a notice of dissolution and cancellation and
-
Improved Understanding of Optune Luna Delivers More Effective TTFields Mesothelioma Treatment
In 2019, the U.S. Food and Drug Administration approved the use of a unique non-invasive protocol for the treatment of malignant pleural mesothelioma. Branded as Optune Luna, Novocure’s TTFields treatment uses electrical fields to disrupt the rare form of cancer’s genetic code. Recently, the company’s researchers released new guidance on the electrical frequency that yields
-
Former Sunbeam Employee’s Mesothelioma Claim Permitted to Proceed
James Myers died of malignant mesothelioma in March of 2018, and since that time his survivors have been working to get justice from those who exposed him to asbestos. Though Sunbeam Equipment Corporation was initially successful in having the case against them dismissed, a recent decision in the Superior Court of Pennsylvania reversed that decision,
-
Journalists Risk Mesothelioma in Battle Environments Where Asbestos is Prevalent
Malignant mesothelioma has long been known as an occupational disease, but in most cases, the rare form of cancer strikes down factory workers, shipyard workers, and others whose work is directly tied to the use of the insulating material asbestos. But a case study published in BMJ Journals noted that asbestos dust raised from the destruction of
-
Cancer Conference Yields Encouraging News for Mesothelioma Patients
The annual meeting of the American Association for Cancer Research presents an opportunity for mesothelioma researchers to share their most recent findings with their colleagues, and this year’s conference was no exception. A presentation by scientists from Barts Cancer Institute at Queen Mary University of London in the United Kingdom revealed that the addition of
-
California-Based Drug Developer Reports Positive Results from Early Test of New Mesothelioma Drug
When searching for a cure for malignant mesothelioma, early evidence that a novel idea can work is cause for celebration. Known as “proof of concept,” it is generally announced when researchers have move beyond testing animal models and can show real potential for use in humans. At the annual meeting of the American Association for
-
Court Denies Brake Grinding Machine Company’s Attempt to Evade Mesothelioma Lawsuit
Choosing who to include among the defendants in a personal injury claim is one of the toughest challenges faced by mesothelioma victims. In their pursuit of justice, they need to identify all of the companies that had a duty to warn them about the dangers of asbestos, and then prove their role in court. While
-
Mesothelioma Concerns Drive EPA Warnings Following Indiana Recycling Plant Fire
Residents of Richmond, Indiana thought chemical-laden fumes from the recent plastics recycling facility fire were their biggest problem, but recent EPA warnings suggest longer-term concerns over the risk of malignant mesothelioma. Debris that’s been found as far as a mile-and-a-half away from the plant has tested positive for chrysotile asbestos.
-
General Contractor Must Face Mesothelioma Victim’s Family in Negligence Case
People who’ve been exposed to asbestos are at risk for malignant mesothelioma, asbestosis, and other serious medical conditions: many of them die. Most blame their illnesses on manufacturers, employers, and others who should have protected them, and many pursue lawsuits seeking compensation for the damages they’ve suffered. The family of one such victim recently filed
-
Study Warns That Cytology Tests Alone Can Miss Mesothelioma Diagnosis
Many physicians will never see a patient with malignant mesothelioma. The asbestos-related form of cancer only appears in approximately 3,000 Americans per year, and both its rareness and the similarity of its symptoms to other illnesses make diagnosis a challenge. A recent study shows that the malignancy can be misdiagnosed when the proper tools aren’t
-
Fast-Track Designation Awarded to New Mesothelioma Drug
Patients diagnosed with malignant mesothelioma have new reason for hope, as the U.S. Food and Drug Administration has granted fast track designation to SynKIR-110, a new drug for the treatment of the rare, asbestos-related form of cancer.
-
Navy Veteran’s Family’s Mesothelioma Case Against Asbestos Company Can Proceed
When someone you love has been diagnosed with malignant mesothelioma and you decide to pursue justice through the legal system, it’s essential that you work with advocates who understand the law. A recent case filed by the family of a U.S. Navy veteran makes this point very clear: because the family filed their claim in
-
Korean Statin Drug Study Inspires Hope for Improved Mesothelioma Treatment
Malignant mesothelioma is a rare form of cancer that is always considered fatal. The average survival time for the aggressive cancer is approximately 18 months, but researchers are working every day to extend and improve that prognosis, as well as patients’ quality of life. Following up on previous studies that suggested that statin drugs boost
-
Despite Asbestos Company Appeal, Court Rules Mesothelioma Widow Can Keep $17 Million Jury Award
Nearly two years after a Washington state jury ordered Scapa Waycross to pay a mesothelioma widow almost $17 million in compensation, a Washington appeals court denied the company’s request to throw out the verdict. Though the asbestos company argued that the jury’s decision was based on “pure speculation” about the cause of Kevan Holdsworth’s illness,
-
Johnson & Johnson Subsidiary Refiles Bankruptcy Case with $8.9 Settlement Offer
When Johnson & Johnson formed its subsidiary LTL Management, its sole purpose was to carry the company’s talc liabilities into Chapter 11 bankruptcy: the move put thousands of mesothelioma and ovarian cancer victims’ personal injury claims on hold. Those claimants got new hope when the Third Circuit rejected the controversial move, but now the company
-
Shipyard Decries Expert Witness Assertions About Asbestos’ Role in Mesothelioma
A malignant mesothelioma lawsuit generally focuses on the victim’s exposure to asbestos and the defendant’s negligence in allowing it to happen, or failing to warn of the mineral’s dangers. Asbestos company strategies vary, with many working to have expert witness testimony blocked on the grounds that it goes too far in its assessment of asbestos’
-
General Electric Attempts to Exclude Expert Testimony in Mesothelioma Case
James Grant Gooding died of malignant mesothelioma on March 22, 2020, less than three weeks after he filed a personal injury lawsuit against several companies he blamed for having exposed him to asbestos. His survivors enlisted expert witnesses to support their wrongful death claim, and in response General Electric filed a motion to exclude their
-
Japanese Researchers Identify a Significant Indicator of Mesothelioma Survival
Patients diagnosed with malignant pleural mesothelioma navigate a confusing and complicated path. Though the disease is always considered fatal and expected survival is notoriously brief, patients tare offered a range of potential treatments based on the specifics of their condition. A recent study conducted by Japanese researchers has identified an important predictor of survival in
